Avotaciclib trihydrochloride

Modify Date: 2024-01-09 20:40:52

Avotaciclib trihydrochloride Structure
Avotaciclib trihydrochloride structure
Common Name Avotaciclib trihydrochloride
CAS Number 1983984-01-5 Molecular Weight 390.66
Density N/A Boiling Point N/A
Molecular Formula C13H14Cl3N7O Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Avotaciclib trihydrochloride


Avotaciclib (BEY1107) trihydrochloride is a potent and orally active inhibitor of cyclin dependent kinase 1 (CDK1). Avotaciclib trihydrochloride can be used for the research of locally advanced or metastatic pancreatic cancer[1].

 Names

Name Avotaciclib trihydrochloride

 Avotaciclib trihydrochloride Biological Activity

Description Avotaciclib (BEY1107) trihydrochloride is a potent and orally active inhibitor of cyclin dependent kinase 1 (CDK1). Avotaciclib trihydrochloride can be used for the research of locally advanced or metastatic pancreatic cancer[1].
Related Catalog
Target

CDK1

References

[1]. Seufferlein T, et, al. Phase I Trials in Pancreatic Cancer. Translational Pancreatic Cancer Research pp 219-232.

 Chemical & Physical Properties

Molecular Formula C13H14Cl3N7O
Molecular Weight 390.66